Leadership

Andrew G. Spencer, Ph.D.

Senior Vice President, Preclinical Research and Development

Dr. Andrew G. Spencer is an experienced research and development scientist who has contributed to programs from drug discovery into Phase 3 development. Since 2004, he has worked to develop new treatments for diseases in therapeutic areas including autoimmunity/inflammation, cardio-renal disease, and gastroenterology. Prior to joining Millendo, Dr. Spencer was vice president of pharmacology/DMPK at Ardelyx and a member of the senior management team. As program manager for the Ardelyx NHE3 inhibitor program, he made extensive contributions to the discovery and development of tenapanor and served as head of alliance management during partnerships with Sanofi and AstraZeneca. He served on multiple drug discovery project teams focused on discovery of new molecular entities and selection of compounds for clinical development. Before his time at Ardelyx, Dr. Spencer made significant early contributions to emerging treatments for celiac disease as a scientist at the Celiac Sprue Research Foundation and Alvine Pharmaceuticals. In addition, he worked on early drug discovery applications of siRNAs at Mirus Bio (now part of Arrowhead Research), and spent two years at humanized monoclonal antibody innovator PDL BioPharma.

Dr. Spencer holds a Ph.D. in biochemistry from Michigan State University and a B.S. in chemistry from Hope College. He completed a N.I.H. Postdoctoral Fellowship at the Howard Hughes Medical Institute at the University of Colorado at Boulder and in the Department of Biochemistry at the University of Wisconsin at Madison.

logo-millendo-with-r-symbol

US Offices

Corporate Headquarters

110 Miller Avenue, Suite 100
Ann Arbor, MI 48104
734-845-9000
millendo@millendo.com

Lexington Office

420 Bedford Street,
Suite 260
Lexington, MA 02420

Europe Office

Lyon Office

Millendo Therapeutics SAS
15 Chemin du Saquin
Espace Européen,
Building G
69130 Ecully
France
Tel +33 472 18 94 28
Fax +33 478 33 36 29

Scroll to Top